China's proposed guidelines regarding the annual revision of its National Drug Reimbursement List could increase pricing pressure for all included drugs. Draft opinions released by China’s National Healthcare Security Administration (NHSA) Wednesday proposed extending price...

China’s National Health Commission announced plans to create a national adjuvant drug list and guidelines that could limit the sales of those drugs. A notice released last week called for the establishment of a system...

Indication Target/marker/ pathway Summary Licensing status Publication and contact information Neurology Alzheimer's disease (AD) Amyloid-b (A4) precursor protein (APP) Mouse and in vitro studies suggest that l-3-n-butylphthalide (l-NBP) could help treat AD. In a mouse...